Home
»
Press Room
»
DNA Sequencing Market Size To Reach $91.88Bn By 2033

DNA Sequencing Market Size To Reach $91.88 Billion By 2033

November 2025 | Report Format: Electronic (PDF)

DNA Sequencing Market Growth & Trends

The global DNA sequencing market size is expected to reach USD 91.88 billion by 2033, registering a CAGR of 22.66% from 2025 to 2033, according to a new report by Grand View Research, Inc. The incorporation of Artificial Intelligence (AI) has increased the utility of genomic data in clinical practices and thus creates a new frontier in the advancement of genomic data analysis. In May 2020, Nvidia Corporation developed new AI tools, genomic sequencing software, and speech recognition technologies to aid the COVID-19 research efforts. Thus, AI accelerates the variant annotation and prioritization in the clinical diagnosis, which drives the market.

Since the completion of the Human Genome Project, the DNA sequencing cost has declined precipitously. The cost of decoding one person’s genome was around USD 50,000 a decade ago and currently has reached nearly USD 600 in the largest genomic centers. Recently, in February 2020, BGI claimed to reduce the cost to sequence the genome to USD 100. This is expected to expand the use of this technology for prenatal tests, cancer screening, and research studies.

With a significant decrease in cost coupled with the availability of funding, several start-ups have entered the market. For instance, in January 2020, Omniome, a startup firm from the U.S., raised USD 60.0 million in Series C financing to speed up the late-stage product development and product launch of its genetic sequencing platform, which consequently fuels market progression.

Request a free sample copy or view report summary: DNA Sequencing Market Report

DNA Sequencing Market Report Highlights

The consumables segment led the DNA sequencing market for the largest revenue share of 48.93% in 2024.
The next-generation sequencing (NGS) segment led the market, accounting for the largest revenue share of 87.51% in 2024.
Based on workflow, the sequencing segment held the largest revenue share of 57.09% in 2024. This step enables the sequencing of the genome and profiling of DNA-protein interactions.
The oncology segment led the market, accounting for the largest revenue share of 25.25% in 2024. Technology holds great potential in the field of clinical research, as well as in the development of cancer diagnostics and therapeutics.
In 2024, the academic research segment accounted for the largest share of the DNA sequencing market at 51.29%.
North America dominated the market, accounting for a revenue share of 50.92% in 2024, driven by strong genomic research infrastructure, widespread use of cutting-edge sequencing technologies, significant investments in precision medicine, and large-scale sequencing projects.

DNA Sequencing Market Segmentation

Grand View Research has segmented the global DNA sequencing market on the basis of on product & services, technology, workflow, application, end use, and region:

DNA Sequencing Product & Service Outlook (Revenue, USD Million, 2021 - 2033)

Instruments
Consumables
Services

DNA Sequencing Technology Outlook (Revenue, USD Million, 2021 - 2033)

Sanger Sequencing
Next-Generation Sequencing
- Whole Genome Sequencing (WGS)
- Whole Exome Sequencing (WES)
- Targeted Sequencing & Resequencing
Third Generation DNA Sequencing
- Single-Molecule Real-Time Sequencing (SMRT)
- Nanopore Sequencing